Infliximab for severe ocular inflammation in patients with Behcet's disease

Detalles Bibliográficos
Autores principales: Sfikakis, P, Markomichelakis, N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833947/
http://dx.doi.org/10.1186/ar957
_version_ 1782178506157850624
author Sfikakis, P
Markomichelakis, N
author_facet Sfikakis, P
Markomichelakis, N
author_sort Sfikakis, P
collection PubMed
description
format Text
id pubmed-2833947
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28339472010-03-08 Infliximab for severe ocular inflammation in patients with Behcet's disease Sfikakis, P Markomichelakis, N Arthritis Res Ther Poster Presentation BioMed Central 2003 2003-09-12 /pmc/articles/PMC2833947/ http://dx.doi.org/10.1186/ar957 Text en
spellingShingle Poster Presentation
Sfikakis, P
Markomichelakis, N
Infliximab for severe ocular inflammation in patients with Behcet's disease
title Infliximab for severe ocular inflammation in patients with Behcet's disease
title_full Infliximab for severe ocular inflammation in patients with Behcet's disease
title_fullStr Infliximab for severe ocular inflammation in patients with Behcet's disease
title_full_unstemmed Infliximab for severe ocular inflammation in patients with Behcet's disease
title_short Infliximab for severe ocular inflammation in patients with Behcet's disease
title_sort infliximab for severe ocular inflammation in patients with behcet's disease
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833947/
http://dx.doi.org/10.1186/ar957
work_keys_str_mv AT sfikakisp infliximabforsevereocularinflammationinpatientswithbehcetsdisease
AT markomichelakisn infliximabforsevereocularinflammationinpatientswithbehcetsdisease

Ejemplares similares